EU-HTA Guidance for Clinical Validity: Misconceptions and Flawed Processes

This review of the scope of the European Health Technology Assessment (EU HTA)’s guidance on clinical trial validity in its randomized controlled trials (RCTs) highlights several key issues that undermine its practical application and effectiveness, including misconceptions, errors, and inconsistenc...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mondher Toumi, Bruno Falissard, Asma Jouini, Samuel Aballéa, Laurent Boyer, Pascal Auquier
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-07-01
Edice:	Journal of Market Access & Health Policy
Témata:	n/a
On-line přístup:	https://www.mdpi.com/2001-6689/13/3/33
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!